{"id":48,"count":6,"description":"<div class=\"scroll-box\">\r\n<h2 style=\"text-align: center\">Udforskning af GLP-1-peptider: Forskningsapplikationer inden for stofskifte og appetitregulering<\/h2>\r\n<em>GLP-1-peptider er en kategori af forskningsforbindelser, der unders\u00f8ges for deres virkning p\u00e5 blodsukkerregulering, appetitundertrykkelse og metabolisk balance. Disse peptider efterligner eller forst\u00e6rker virkningen af glucagon-like peptide-1, et hormon, der spiller en central rolle i glukosehom\u00f8ostase og energiindtag. I laboratoriemilj\u00f8er unders\u00f8ges GLP-1-peptider almindeligvis for deres potentiale inden for modeller for fedme, type 2-diabetes og v\u00e6gtkontrol. <\/em>\r\n\r\nGLP-1 peptides are a class of research compounds that mimic or enhance the activity of glucagon-like peptide-1, a hormone involved in appetite control, insulin secretion, and glucose metabolism. In scientific studies, these peptides are explored for their ability to suppress hunger, promote fat loss, and regulate blood sugar levels, making them a major focus in research targeting obesity, type 2 diabetes, and other metabolic disorders.\r\n\r\nGLP-1 receptor agonists work by activating incretin pathways (GLP-1, GIP, and glucagon receptors), which collectively help improve insulin sensitivity, slow gastric emptying, reduce food intake, and increase metabolic expenditure. More advanced compounds in this class also target multiple receptors to enhance metabolic effects, offering new possibilities for studying complex weight-related mechanisms in lab settings.\r\n\r\n<em><strong>Ansvarsfraskrivelse: <\/strong>Alle GLP-1-peptider, der henvises til her, er udelukkende beregnet til laboratorieforskning. Eventuelle menneskelige udfald, der n\u00e6vnes, er udelukkende baseret p\u00e5 fund fra dyremodeller eller kliniske data og m\u00e5 ikke fortolkes som medicinsk r\u00e5dgivning eller terapeutiske anbefalinger.<\/em>\r\n<h2>Hvad er GLP-1-receptoragonistpeptider?<\/h2>\r\nGLP-1 receptor agonist peptides are synthetic compounds designed to replicate or enhance the effects of glucagon-like peptide-1 (GLP-1), an incretin hormone released by the gut after eating. In research settings, GLP-1 is known for its ability to stimulate insulin secretion, suppress appetite, slow gastric emptying, and regulate blood sugar. However, the natural hormone breaks down quickly in the body, prompting the development of longer-lasting analogs for laboratory use.\r\n\r\nModern GLP-1 peptides are engineered for increased stability and often include multi-receptor activity. In addition to GLP-1 activation, some of these peptides also target:\r\n<ul>\r\n \t<li><strong>GIP (glukoseafh\u00e6ngig insulinotropisk polypeptid):<\/strong> Forbedrer frigivelsen af insulin og p\u00e5virker fedtstofskiftet<\/li>\r\n \t<li><strong>Glukagonreceptorer:<\/strong> Fremmer fedtoxidation, thermogenese og energiforbrug<\/li>\r\n<\/ul>\r\nDisse kombinerede effekter g\u00f8r GLP-1-receptoragonister v\u00e6rdifulde i pr\u00e6kliniske forskningsmodeller med fokus p\u00e5:\r\n<ul>\r\n \t<li>V\u00e6gttab og appetitd\u00e6mpning<\/li>\r\n \t<li>Fedme og metabolisk syndrom<\/li>\r\n \t<li>Insulinresistens og glukosehomeostase<\/li>\r\n \t<li>Unders\u00f8gelser af fedtmasse og energibalance<\/li>\r\n<\/ul>\r\nPeptider som Semaglutid, Tirzepatid og Retatrutid anvendes almindeligvis i denne forskningskategori p\u00e5 grund af deres kraftfulde metaboliske og v\u00e6gtreducerende virkninger.\r\n<h2>Virkningsmekanismer for GLP-1-peptider<\/h2>\r\nGLP-1 receptor agonist peptides work by mimicking or enhancing natural gut hormones that regulate hunger, insulin release, and energy metabolism. Each peptide in this category acts on different combinations of receptors to drive metabolic effects. Here's a breakdown of the mechanisms by individual peptide:\r\n\r\n<strong>Semaglutid<\/strong>\r\n<ul>\r\n \t<li>Semaglutid, som er en GLP-1-receptoragonist, efterligner naturlige incretinhormoner.<\/li>\r\n \t<li>Det forsinker maves\u00e6kkens t\u00f8mning, hvilket forl\u00e6nger m\u00e6thedsfornemmelsen og reducerer kalorieindtaget.<\/li>\r\n \t<li>\u00d8ger insulinsekretionen som svar p\u00e5 glukose og s\u00e6nker blodsukkerniveauet.<\/li>\r\n \t<li>Dens langtidsvirkende udformning underst\u00f8tter dosering en gang om ugen i forskningsmodeller og opretholder en stabil receptoraktivering over tid.<\/li>\r\n<\/ul>\r\n<strong>Tirzepatid<\/strong>\r\n<ul>\r\n \t<li>En dobbelt agonist af b\u00e5de GLP-1- og GIP-receptorer (glukoseafh\u00e6ngig insulinotropisk polypeptid).<\/li>\r\n \t<li>Forbedrer insulinf\u00f8lsomhed og -sekretion, samtidig med at glucagonniveauerne moduleres.<\/li>\r\n \t<li>Undtrykker appetiten kraftigt og forbedrer den glyk\u00e6miske kontrol, hvilket f\u00f8rer til et markant v\u00e6gttab.<\/li>\r\n \t<li>I SURPASS-kliniske studier overgik Tirzepatide Semaglutide med hensyn til at reducere kropsv\u00e6gt og blodsukker.<\/li>\r\n<\/ul>\r\n<strong>Retatrutide<\/strong>\r\n<ul>\r\n \t<li>En trippelreceptoragonist, der retter sig mod GLP-1-, GIP- og glucagonreceptorer.<\/li>\r\n \t<li>Aktiverer glucagon-veje for at \u00f8ge energiforbruget og basalstofskiftet.<\/li>\r\n \t<li>Fremmer lipolyse og fedtoxidation, hvilket g\u00f8r det til et af de mest potentte peptider, der er unders\u00f8gt til reduktion af kropsfedt.<\/li>\r\n \t<li>Tidlige fors\u00f8g p\u00e5 mennesker viser st\u00f8rre v\u00e6gttab end andre GLP-1-baserede pr\u00e6parater.<\/li>\r\n<\/ul>\r\nTil sammen repr\u00e6senterer disse peptider en kraftfuld klasse af metaboliske regulatorer i laboratoriestudier, som giver indsigt i appetitkontrol, insulindynamik og energibalance.\r\n<h2>Forskning og kliniske resultater<\/h2>\r\nGLP-1-peptider som Semaglutid, Tirzepatid og Retatrutid har omformet metabolisk forskning p\u00e5 grund af deres kraftfulde effekter p\u00e5 v\u00e6gttab, appetitregulering og glukosekontrol. Hver er blevet unders\u00f8gt i omfattende kliniske og laboratoriem\u00e6ssige fors\u00f8g med konsekvent st\u00e6rke resultater:\r\n<h3>Semaglutid<\/h3>\r\n<ul>\r\n \t<li>I de kliniske STEP-unders\u00f8gelser tabte overv\u00e6gtige fors\u00f8gspersoner uden diabetes i gennemsnit ca. 15% af deres kropsv\u00e6gt over en periode p\u00e5 68 uger.<\/li>\r\n \t<li>Betydelige reduktioner blev ogs\u00e5 set i taljem\u00e5l, fastende insulin og inflammatoriske biomark\u00f8rer.<\/li>\r\n \t<li>Deltagerne rapporterede om nedsat appetit inden for f\u00e5 dage, hvilket forbedrede overholdelsen i langsigtede forskningsprotokoller.<\/li>\r\n<\/ul>\r\n<h3>Tirzepatid<\/h3>\r\n<ul>\r\n \t<li>SURMOUNT-1-unders\u00f8gelsen viste et v\u00e6gttab p\u00e5 ca. 22,51 TP3T over en periode p\u00e5 72 uger.<\/li>\r\n \t<li>Tirzepatid forbedrede ogs\u00e5 HbA1c-niveauer, insulinf\u00f8lsomhed og lipidprofiler.<\/li>\r\n \t<li>Dens dobbelte GIP- og GLP-1-aktivitet gjorde den overlegen i forhold til GLP-1-agonister alene i sammenlignende studier.<\/li>\r\n \t<li>Forskning viser fordele p\u00e5 tv\u00e6rs af b\u00e5de diabetes- og ikke-diabetes-metaboliske modeller.<\/li>\r\n<\/ul>\r\n<h3>Retatrutide<\/h3>\r\n<ul>\r\n \t<li>Et fase II-fors\u00f8g (2023) viste et fedttab p\u00e5 op til 24,21 TP3T hos overv\u00e6gtige\/fede deltagere, hvilket er det h\u00f8jeste, der hidtil er observeret inden for incretin-klassen.<\/li>\r\n \t<li>Gennem aktivering af glukagonreceptoren \u00f8gede det energiforbruget og fedtoxidationen ud over det, der opn\u00e5s via GLP-1\/GIP-mekanismer alene.<\/li>\r\n \t<li>Viste ogs\u00e5 fordele ved blodtryk, triglycerider og leverfedt.<\/li>\r\n<\/ul>\r\n<strong>Overordnede indsigter<\/strong>\r\n\r\nAlle tre peptider viser konsekvent:\r\n<ul>\r\n \t<li>Hurtig appetitundertrykkelse<\/li>\r\n \t<li>Reduceret fedtmasse, taljeomkreds og fastende insulin<\/li>\r\n \t<li>Forbedrede kardiometaboliske mark\u00f8rer (kolesterol, blodtryk, CRP)<\/li>\r\n \t<li>Lange halveringstider g\u00f8r dem ideelle til ugentlig eller to-ugentlig forskningsdosering<\/li>\r\n<\/ul>\r\nDisse fund har cementeret GLP-1-receptoragonister som hj\u00f8rnestenstoffer inden for fedme- og metabolisk forskning.\r\n<h2>Sikkerheds- og reguleringsm\u00e6ssig indsigt<\/h2>\r\nGLP-1 peptide research continues to evolve, with several compounds already approved for clinical use and others in advanced trial phases:\r\n\r\nSemaglutide is FDA-approved for both type 2 diabetes (as Ozempic) and chronic weight management (as Wegovy). It is widely studied in metabolic models and has a well-documented safety profile in both diabetic and non-diabetic populations.\r\n\r\nTirzepatide, a dual GLP-1\/GIP agonist, is also FDA-approved for type 2 diabetes (as Mounjaro) and is under review for obesity-related approvals, following positive SURMOUNT trial data.\r\n\r\nRetatrutide, the triple agonist (GLP-1, GIP, glucagon), remains investigational but has shown groundbreaking results in Phase II trials, with potential to become a new class leader in fat loss and metabolic support research.\r\n\r\n<strong>Almindeligt observerede effekter i forskning omfatter:<\/strong>\r\n<ul>\r\n \t<li>Kvalme<\/li>\r\n \t<li>Forstoppelse<\/li>\r\n \t<li>Appetitd\u00e6mpning<\/li>\r\n \t<li>Disse er typisk dosisafh\u00e6ngige og aftager over tid i langtidsstudier.<\/li>\r\n<\/ul>\r\n<strong>Brugsretningslinjer:<\/strong>\r\n<ul>\r\n \t<li>Anvendes i kontrollerede laboratoriemilj\u00f8er med fokus p\u00e5 fedme, insulinresistens eller energistofskifte.<\/li>\r\n \t<li>Oprethold sterilt teknik, k\u00f8lek\u00e6deopbevaring og protokol dokumentation for at sikre reproducerbarhed.<\/li>\r\n<\/ul>\r\n<strong>Vigtig p\u00e5mindelse:<\/strong>\r\n\r\nAlle dr\u00f8ftede peptider er udelukkende beregnet til laboratorieforskning. De er ikke godkendt til human administration, medmindre det sker under regulerede kliniske fors\u00f8g eller i receptpligtige sammenh\u00e6nge.\r\n<h2>Bedste GLP-1 peptider til forskning<\/h2>\r\nGLP-1-peptider har revolutioneret den metaboliske og fedmerelaterede forskning. F\u00f8lgende peptider skiller sig ud p\u00e5 grund af deres veldokumenterede effekt i prekliniske og kliniske modeller:\r\n<ul>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/da\/product\/buy-semaglutide-5mg\/\"><strong>Semaglutid<\/strong><\/a> \u2013 En velunders\u00f8gt GLP-1-receptoragonist, der er kendt for sin rolle i appetitd\u00e6mpning, glukoseregulering og reduktion af fedtmasse. Stoffet har vist et konsekvent v\u00e6gttab p\u00e5 ca. 15% i langvarige unders\u00f8gelser af fedme.<\/li>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/da\/product\/buy-tirzepatide-5mg\/\"><strong>Tirzepatid<\/strong><\/a> \u2013 En dobbelt GLP-1\/GIP-agonist, der \u00f8ger insulinf\u00f8lsomheden og reducerer kropsv\u00e6gten endnu mere effektivt end semaglutid. Kliniske fors\u00f8g som SURMOUNT-1 viste et gennemsnitligt v\u00e6gttab p\u00e5 22,51 TP3T hos de behandlede fors\u00f8gspersoner.<\/li>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/da\/product\/buy-retatrutide-5mg\/\"><strong>Retatrutide<\/strong><\/a> \u2013 En tredobbelt agonist af n\u00e6ste generation, der virker p\u00e5 GLP-1-, GIP- og glukagonreceptorerne. Tidlige fors\u00f8g viser et fedttab p\u00e5 op til 24,21 TP3T, hvilket g\u00f8r det til et af de mest potente peptider i den aktuelle forskning inden for fedme.<\/li>\r\n<\/ul>\r\n<h2>Laboratoriebrug &amp; Rekonstituering<\/h2>\r\nGLP-1-peptider som Semaglutid, Tirzepatid og Retatrutid skal rekonstitueres korrekt og h\u00e5ndteres under sterile laboratorieforhold for at opretholde stabilitet og n\u00f8jagtighed i forskningen.\r\n\r\n<strong>Rekonstituering<\/strong>De fleste GLP-1-peptider kan rekonstitueres ved hj\u00e6lp af bakteriostatisk vand eller sterilt saltvand. Injic\u00e9r langsomt opl\u00f8sningsmidlet ned langs h\u00e6tteglassets inderv\u00e6g for at undg\u00e5 skumdannelse, og sving forsigtigt indtil det er fuldst\u00e6ndigt opl\u00f8st.\r\n\r\n<strong>Opbevaring<\/strong>:\r\n<ul>\r\n \t<li>Lyofiliserede peptider kan opbevares ved stuetemperatur og beskyttet mod lys.<\/li>\r\n \t<li>Rekonstituerede peptider forbliver stabile i 30-60+ dage, n\u00e5r de opbevares i k\u00f8leskab ved 2\u20138 \u00b0C.<\/li>\r\n<\/ul>\r\n<strong>Dosering i prekliniske modeller:<\/strong>\r\n\r\nStandarddosering varierer fra 0,01\u20130,2 mg\/kg til mus eller rotter, afh\u00e6ngigt af fors\u00f8gsopstillingen og forskningsm\u00e5lene.\r\n<h3>Almindelige forskningsm\u00e5l:<\/h3>\r\n<ul>\r\n \t<li>Kropsv\u00e6gt over tid<\/li>\r\n \t<li>Appetitd\u00e6mpning og overv\u00e5gning af madindtag<\/li>\r\n \t<li>Glukosetoleranstest<\/li>\r\n \t<li>Analyse af fedtpudemasse og -sammens\u00e6tning<\/li>\r\n \t<li>Inkrethormonaktivitet, herunder insulin-, GLP-1-, GIP- og glucagonanalyser<\/li>\r\n<\/ul>\r\nDisse peptider er udelukkende beregnet til laboratorieforskning, og al h\u00e5ndtering skal f\u00f8lge etiske protokoller og sterile best practice-standarder.\r\n<h2>Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\r\n<h3>Hvilket GLP-1-peptid giver det st\u00f8rste v\u00e6gttab?<\/h3>\r\nRetatrutide har vist det mest markante v\u00e6gttab (~24%) i tidlige kliniske fors\u00f8g.\r\n<h3>Kan peptider staples for bedre resultater?<\/h3>\r\nNormalt ikke. Retatrutide aktiverer allerede GLP-1-, GIP- og glucagon-receptorerne, hvilket g\u00f8r yderligere \"stacking\" un\u00f8dvendig.\r\n<h3>Hvad skal jeg g\u00f8re, hvis et peptid ikke opl\u00f8ses fuldst\u00e6ndigt?<\/h3>\r\nSving h\u00e6teglaslet forsigtigt rundt, ryst det ikke. Let opvarmning (i et 37\u00b0C vandbad) kan hj\u00e6lpe med opl\u00f8sningen.\r\n<h3>Er der forskelle i receptoraffinitet blandt disse peptider?<\/h3>\r\nYes. Semaglutide selectively targets GLP-1 receptors, while Tirzepatide and Retatrutide act on multiple receptors for a broader effect.\r\n\r\nTo finish up, GLP-1 peptides represent a leading edge in metabolic research, offering compelling avenues to study fat loss, insulin regulation, and appetite suppression. Peptides such as Semaglutide, Tirzepatide, and Retatrutide have shown significant effects in both preclinical and clinical models, making them valuable tools for obesity and diabetes-related investigations.\r\n\r\nExplore the full GLP-1 peptide catalog at CellPeptides to support your next metabolic research project.\r\n\r\n<\/div>","link":"https:\/\/cellpeptides.com\/da\/purpose\/glp-1-peptides\/","name":"GLP-1 forskningspeptider","slug":"glp-1-peptides","taxonomy":"product_cat","parent":0,"meta":[],"menu_order":0,"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides<\/title>\n<meta name=\"description\" content=\"Shop GLP-1 receptor agonists for appetite, glucose &amp; metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA &amp; EU\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/da\/purpose\/glp-1-peptides\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Shop GLP-1 receptor agonists for appetite, glucose &amp; metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA &amp; EU\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/da\/purpose\/glp-1-peptides\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"CollectionPage\",\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/\",\"url\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/\",\"name\":\"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"description\":\"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb\"},\"inLanguage\":\"da-DK\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Research Peptides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"K\u00f8b GLP-1 Peptider til Metaboliske Studier (In-vitro) - CellPeptides","description":"K\u00f8b GLP-1-receptoragonister til appetit-, glukose- og metabolisk forskning \u2013 Semaglutid, Tirzepatid, Retatrutid. Hurtig forsendelse i USA og EU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/da\/purpose\/glp-1-peptides\/","og_locale":"da_DK","og_type":"article","og_title":"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides","og_description":"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU","og_url":"https:\/\/cellpeptides.com\/da\/purpose\/glp-1-peptides\/","og_site_name":"CellPeptides","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"CollectionPage","@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/","url":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/","name":"K\u00f8b GLP-1 Peptider til Metaboliske Studier (In-vitro) - CellPeptides","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"description":"K\u00f8b GLP-1-receptoragonister til appetit-, glukose- og metabolisk forskning \u2013 Semaglutid, Tirzepatid, Retatrutid. Hurtig forsendelse i USA og EU","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb"},"inLanguage":"da-DK"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Research Peptides"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"CellPeptides","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"CellPeptides","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/da\/wp-json\/wp\/v2\/product_cat\/48","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/da\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/cellpeptides.com\/da\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"wp:post_type":[{"href":"https:\/\/cellpeptides.com\/da\/wp-json\/wp\/v2\/product?product_cat=48"}],"curies":[{"name":"godt spillet","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}